spacer
The Healthcare Sales & Marketing Network celebrates 28 years serving the medical sales & marketing community.Connecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product LinesConnecting Medical Sales Reps with MedTech/BioPharma Recruiters and Independent Reps with and New Product Lines

Healthcare News Roundup: Biopharmaceutical

 HSMN NewsFeed - 6 Oct 2010
FDA Approves Pharmaxis' ARIDOL (Mannitol Inhalation Powder) Bronchial Challenge Test Kit for the Assessment of Bronchial Hyperresponsiveness
Biopharmaceuticals Diagnostics FDA
 HSMN NewsFeed - 6 Oct 2010
Cortex Obtains Exclusive Worldwide Rights for the Combination of AMPAKINE(R) and mGluR5 Compounds for the Treatment of Fragile X
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 6 Oct 2010
Angiotech Pharmaceuticals, Inc. Announces Commencement of Arbitration and Litigation Proceedings by QSR Holdings, Inc. Against the Company And Certain of Its Subsidiaries
Biopharmaceuticals Litigation
 HSMN NewsFeed - 6 Oct 2010
New Data Demonstrate Treatment With STELARA(R) (Black Triangle Drug) (ustekinumab) Results in Sustained Improvements in Psoriasis Severity and Quality of Life up to Three Years
Biopharmaceuticals Dermatology
 HSMN NewsFeed - 5 Oct 2010
New Leaf Venture Partners Invests in $35.4 (£22.4) Million Series A Financing of Convergence Pharmaceuticals
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 5 Oct 2010
Accera, Inc. Appoints Dr. Thomas Werner President & CEO and Announces FDA Acceptance of IND Application for AC-1204 for Mild-to-Moderate Alzheimer's Disease
Biopharmaceuticals Neurology Personnel FDA
 HSMN NewsFeed - 5 Oct 2010
NormOxys, Inc. Appoints Dr. Gerard Riedel as Vice President, Regulatory Affairs and Program Management
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2010
NKT Therapeutics Announces Hiring of Barbara Finck, M.D. as Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2010
NGM Biopharmaceuticals Names William J. Rieflin Chief Executive Officer and Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2010
Anacor Pharmaceuticals Appoints Geoffrey M. Parker as Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 5 Oct 2010
RHUCIN Clinical Trial Data Published in the Journal of Allergy and Clinical Immunology
Biopharmaceuticals
 HSMN NewsFeed - 4 Oct 2010
Genzyme Board Urges Shareholders to Take No Action On sanofi-aventis’ Unsolicited Tender Offer
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Oct 2010
FDA Issues Complete Response Letter to Johnson & Johnson Pharmaceutical Research & Development Regarding New Drug Application for Tapentadol Extended Release
Biopharmaceuticals FDA
 HSMN NewsFeed - 4 Oct 2010
Celsion Receives Positive FDA Guidance for its New Drug Application for ThermoDox(R) to Treat Primary Liver Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 4 Oct 2010
Sanofi-aventis Commences Tender Offer to Acquire All Outstanding Shares of Genzyme for $69 per Share in Cash
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 4 Oct 2010
New American Therapeutics Acquires Antiviral Drug Denavir(R)
Biopharmaceuticals Acquisitions
 HSMN NewsFeed - 1 Oct 2010
Phase III Data Showing Improved Survival With Jevtana(R) (cabazitaxel) Injection in Second-Line Advanced Prostate Cancer Published in The Lancet
Biopharmaceuticals Oncology
 HSMN NewsFeed - 1 Oct 2010
ZIOPHARM Oncology Appoints Michael G. King, Jr. as Senior Vice President of Corporate Development & Communication
Biopharmaceuticals Oncology Personnel
 HSMN NewsFeed - 29 Sep 2010
Tobira Therapeutics Inc. Raises $31 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 29 Sep 2010
Mersana Therapeutics Appoints Nicholas Bacopoulos President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2010
Tigris Pharmaceuticals Appoints Neil Flanzraich to Executive Chairman of the Board
Biopharmaceuticals Personnel
 HSMN NewsFeed - 28 Sep 2010
Apax Partners to Sell Qualitest Pharmaceuticals to Endo Pharmaceuticals for $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2010
Endo Pharmaceuticals Announces Agreement to Acquire Qualitest Pharmaceuticals for $1.2 Billion
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 28 Sep 2010
AstraZeneca UK Receives Positive Decision For Seroquel XL(R)[Black Triangle Drug] (Quetiapine Prolonged Release) as an Add-On Treatment of Major Depressive Disorder
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 28 Sep 2010
Valeant and Biovail Complete Merger
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Sep 2010
Pfizer Discontinues Phase 3 Trial of SUTENT(R) in Advanced Castration-Resistant Prostate Cancer
Biopharmaceuticals Oncology
 HSMN NewsFeed - 27 Sep 2010
SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 27 Sep 2010
TetraLogic Expands Series C Financing with New Investor Pfizer Ventures
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 27 Sep 2010
Centocor Ortho Biotech Inc. Submits Application to FDA Seeking to Expand SIMPONI(R) Label in Treatment of Rheumatoid Arthritis
Biopharmaceuticals FDA
 HSMN NewsFeed - 27 Sep 2010
DecImmune Therapeutics Secures $3.2 Million in Development Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 24 Sep 2010
Warner Chilcott Agrees to Terminate Existing Co-Promotion Agreement and Acquire U.S. Rights to Enablex(R) Overactive Bladder Treatment for $400 Million in Cash
Biopharmaceuticals Urology Acquisitions
 HSMN NewsFeed - 23 Sep 2010
Takeda Responds to Announcement about Suspension of Rosiglitazone Marketing Authorization in Europe and Restrictions in the U.S.
Biopharmaceuticals Endocrinology Regulatory
 HSMN NewsFeed - 23 Sep 2010
BioMarin Appoints William Young and Kenneth Bate to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 23 Sep 2010
Portola Pharmaceuticals Appoints Jean-Jacques Bienaime to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 22 Sep 2010
Biogen Idec Makes Statement About U.S. FDA Approval of Gilenya
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Sep 2010
Novartis gains FDA approval for Gilenya, a novel first-line multiple sclerosis treatment shown to significantly reduce relapses and delay disability progression
Biopharmaceuticals Neurology FDA
 HSMN NewsFeed - 22 Sep 2010
Novartis Drug SOM230 is First Medical Therapy to Show Efficacy in a Phase III Trial in Cushing's Disease, a Debilitating Hormonal Disorder
Biopharmaceuticals
 HSMN NewsFeed - 21 Sep 2010
Jeffrey A. Winton Named Vice President of Communications at Eli Lilly and Company
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Sep 2010
NewBridge Pharmaceuticals Completes $12 Million First Close of Series B Financing, Announces Senior Executive Appointments
Biopharmaceuticals Venture Capital Personnel
 HSMN NewsFeed - 17 Sep 2010
Aradigm Presents Results Supporting Once-Daily Dosing With Its Inhaled Liposomal Ciprofloxacin Formulations at the 2010 European Respiratory Society (ERS) Annual Congress
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 17 Sep 2010
Eddingpharm (Cayman) Inc. Announces Closing of Series B Funding
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 16 Sep 2010
Itero Biopharmaceuticals Appoints Debanjan Ray to Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Sep 2010
FluoroPharma Inc. Appoints Mr. Thijs Spoor as Chief Executive Officer and Director
Biopharmaceuticals Radiology Oncology Personnel
 HSMN NewsFeed - 16 Sep 2010
Steven Lo Joins Corcept as Vice President of Commercial Operations
Biopharmaceuticals Personnel
 HSMN NewsFeed - 15 Sep 2010
Ensemble Appoints Ted Hibben as Senior Vice President, Corporate Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2010
AAIPharma Services Corp. Names Patrick Walsh Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Sep 2010
Cell Therapeutics to Appeal FDA Decision on New Drug Application (NDA) for Pixantrone to Treat Relapsed/Refractory Aggressive Non-Hodgkin's Lymphoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 13 Sep 2010
Relypsa Raises $70 Million in Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 13 Sep 2010
Rexahn Pharmaceuticals Announces the Appointment of Peter Brandt and Richard Kivel to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2010
Aegerion Pharmaceuticals Appoints Marc Beer as CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2010
Seattle Genetics Announces Phase IIb Trial of Lintuzumab (SGN-33) in Patients with Acute Myeloid Leukemia (AML) Did Not Meet Primary Endpoint
Biopharmaceuticals Oncology
 HSMN NewsFeed - 13 Sep 2010
AVEO Pharmaceuticals, Inc. Appoints Michael P. Bailey to the Newly Created Position of Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Sep 2010
Pharming signs commercialization agreement with Santarus for Rhucin(R) in North America
Biopharmaceuticals
 HSMN NewsFeed - 10 Sep 2010
FDA Approves New Dosing for FASLODEX(R) (fulvestrant) Injection in Treatment of Metastatic Breast Cancer in HR+ Postmenopausal Women
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 10 Sep 2010
Bristol-Myers Squibb Begins Tender Offer to Acquire ZymoGenetics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 9 Sep 2010
Shire Expands Pipeline to Treat Orphan Muscle Diseases Through Collaboration With Acceleron Pharma
Biopharmaceuticals Licensing
 HSMN NewsFeed - 8 Sep 2010
Zyngenia, Inc. Raises $15 Million in Series A Extension Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Sep 2010
iPierian Announces Second Close of $28 Million Series B Financing
Biopharmaceuticals Regenerative Medicine Venture Capital
 HSMN NewsFeed - 8 Sep 2010
Tekmira Pharmaceuticals Strengthens Management Team With Addition of Paul Brennan as Senior Vice President, Business Development
Biopharmaceuticals Personnel
 HSMN NewsFeed - 8 Sep 2010
Curaxis Pharmaceutical Corp CEO Patrick S. Smith Announces Plans for Further Clinical Trials for Alzheimer's Treatment
Biopharmaceuticals Neurology
 HSMN NewsFeed - 8 Sep 2010
Rhythm Closes $40 Million Series A Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 8 Sep 2010
Onyx Pharmaceuticals Announces Carfilzomib Development and Commercialization Agreement with Ono Pharmaceutical for Japan
Biopharmaceuticals Oncology
 HSMN NewsFeed - 8 Sep 2010
Abbott Completes Acquisition of Piramal's Healthcare Solutions Business, Becomes Leading Pharmaceutical Company in India
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 8 Sep 2010
Jennerex and Transgene Enter Into an Exclusive Partnership for the Development and Commercialization of JX-594 for the Treatment of Cancers
Biopharmaceuticals Oncology
 HSMN NewsFeed - 7 Sep 2010
Bristol-Myers Squibb to Acquire ZymoGenetics
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 7 Sep 2010
FDA Advisory Committee Recommends Approval of Forest Laboratories' Ceftaroline Fosamil for the Treatment of Community Acquired Bacterial Pneumonia and Complicated Skin and Skin Structure Infections
Biopharmaceuticals FDA
 HSMN NewsFeed - 7 Sep 2010
Watson's Generic Yasmin(R) Receives FDA Approval
Biopharmaceuticals Generics FDA
 HSMN NewsFeed - 7 Sep 2010
Court Denies Sandoz/Momenta's Summary Judgment of Invalidity in Copaxone(R) Litigation
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 7 Sep 2010
Cubist Pharmaceuticals Announces Promotion of Steven C. Gilman, Ph.D., to EVP, Research and Development and Chief Scientific Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Sep 2010
James F. Szigethy Named Curemark's Director of New Product Development
Biopharmaceuticals Neurology Personnel
 HSMN NewsFeed - 7 Sep 2010
La Jolla Pharmaceutical Company Provides Update on Search for Clinical Products to In-License or Acquire
Biopharmaceuticals Licensing
 HSMN NewsFeed - 7 Sep 2010
Watson Confirms Combigan(R) Patent Challenge
Biopharmaceuticals Generics Ophthalmology Litigation
 HSMN NewsFeed - 7 Sep 2010
NeoStem Appoints Distinguished Businessman as New President and Managing Director NeoStem China
Biopharmaceuticals Regenerative Medicine Personnel
 HSMN NewsFeed - 7 Sep 2010
Alethia Biotherapeutics Secures C$9.6 Million in Series A Financing to Fund Its Therapeutic Monoclonal Antibody Product Pipeline
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 7 Sep 2010
Protalix BioTherapeutics Names Tzvi Palash Chief Operating Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 3 Sep 2010
Celldex Therapeutics Regains Worldwide Rights to Rindopepimut (CDX-110)
Biopharmaceuticals Oncology
 HSMN NewsFeed - 3 Sep 2010
Gilead Sciences Submits European Marketing Application for Once-Daily Single-Tablet Regimen of Truvada(R) and TMC278 for the Treatment of HIV Infection
Biopharmaceuticals HIV/AIDS
 HSMN NewsFeed - 3 Sep 2010
Santhera and Ipsen Enter into Licensing Agreement for Fipamezole for the Treatment of Dyskinesia in Parkinson's Disease
Biopharmaceuticals Neurology Licensing
 HSMN NewsFeed - 1 Sep 2010
Pfizer to Acquire FoldRx Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 1 Sep 2010
Celator(R) Pharmaceuticals Raises $20 Million in Series D Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 1 Sep 2010
Archimedes Pharma Receives European Marketing Authorisation for PecFent(R) for the Treatment of Breakthrough Cancer Pain
Biopharmaceuticals Regulatory
 HSMN NewsFeed - 1 Sep 2010
Inspire Names Robert Savel as Senior Vice President and Chief Technical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 1 Sep 2010
Microplasmin Meets Primary Endpoint in Second Phase III Trial in VMA, Confirms Positive Findings of First Trial
Biopharmaceuticals Ophthalmology
 HSMN NewsFeed - 31 Aug 2010
Allergan, Inc. Receives FDA Approval for LUMIGAN(R) 0.01% as First-Line Therapy Indicated for the Reduction of Elevated Intraocular Pressure in Glaucoma Patients
Biopharmaceuticals Ophthalmology FDA
 HSMN NewsFeed - 31 Aug 2010
Rivaroxaban Successfully Demonstrated Non-Inferiority Compared to Standard of Care for the Prevention of Recurrent Venous Thromboembolism in Pivotal Phase 3 Study
Biopharmaceuticals
 HSMN NewsFeed - 30 Aug 2010
Meda acquires Alaven, a US specialty pharma company
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Aug 2010
Otonomy Closes $38.5 Million Series B Financing
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 30 Aug 2010
King Pharmaceuticals Appoints Jeffrey Bailey Chief Commercial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2010
Genzyme Confirms Receipt of Unsolicited Proposal
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 30 Aug 2010
Easton Pharmaceuticals Inc. Announces Experienced CFO Appointment to Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 30 Aug 2010
Teriflunomide Significantly Reduced Annualized Relapse Rate and was Well Tolerated in MS Patients
Biopharmaceuticals Neurology
 HSMN NewsFeed - 30 Aug 2010
sanofi-aventis Announces Non-Binding Offer to Acquire Genzyme
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 27 Aug 2010
Novartis receives FDA approval of Tekamlo, a single-pill combination of aliskiren and amlodipine to treat high blood pressure
Biopharmaceuticals Cardiology FDA
 HSMN NewsFeed - 27 Aug 2010
Genentech Provides Update on FDA Application for T-DM1
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 26 Aug 2010
XOMA Appoints Jack L. Wyszomierski to Its Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 26 Aug 2010
Celgene Corporation Announces Appointment of Jacqualyn A. Fouse as Senior Vice President and Chief Financial Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 25 Aug 2010
Actelion Pharmaceuticals Announces FDA Approval of Brand Name for Commercially Available VELETRI(R) (epoprostenol for injection) for Pulmonary Arterial Hypertension
Biopharmaceuticals FDA
 HSMN NewsFeed - 25 Aug 2010
Bristol-Myers Squibb and Pfizer Inc Evaluate Unmet Need in Patients with Atrial Fibrillation
Biopharmaceuticals Cardiology
 HSMN NewsFeed - 25 Aug 2010
Somaxon Pharmaceuticals Announces Silenor(R) Co-Promotion Agreement with Procter & Gamble
Biopharmaceuticals
 HSMN NewsFeed - 24 Aug 2010
Celsion Receives Fast Track Designation for ThermoDox(R) Development Program to Treat Primary Liver Cancer
Biopharmaceuticals Drug Delivery Oncology FDA
 HSMN NewsFeed - 24 Aug 2010
Baxter Announces Manufacturing, Supply and Distribution Agreement with Kamada for GLASSIA
Biopharmaceuticals Distribution
 HSMN NewsFeed - 23 Aug 2010
Novo Nordisk Inc. Announces Exclusive Agreement With Upsher-Smith Laboratories, Inc. to Market Vagifem(R) 10 mcg
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2010
Archimedes Pharma US Announces New US Headquarters In Bedminster, New Jersey
Biopharmaceuticals
 HSMN NewsFeed - 23 Aug 2010
Taligen Closes $10 Million Series B Financing Tranche
Biopharmaceuticals Venture Capital
 HSMN NewsFeed - 20 Aug 2010
Impax Laboratories Confirms Patent Challenge Relating to VYTORIN(R), 10 mg/80 mg
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 20 Aug 2010
Hospira Announces CEO Succession Plan
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 Aug 2010
REVLIMID(R) Approved for Treatment of Deletion 5q Myelodysplastic Syndromes in Japan
Biopharmaceuticals Oncology Regulatory
 HSMN NewsFeed - 19 Aug 2010
Human Genome Sciences and GlaxoSmithKline Announce FDA Priority Review Designation for BENLYSTA(R) (belimumab) as a Potential Treatment for Systemic Lupus Erythematosus
Biopharmaceuticals FDA
 HSMN NewsFeed - 18 Aug 2010
Ipilimumab Receives FDA Priority Review Designation for Adult Patients with Previously Treated Advanced Melanoma
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Aug 2010
ImmunoGen, Inc. Announces Orphan Drug Designation Granted to Lorvotuzumab Mertansine for Treatment of Small-Cell Lung Cancer
Biopharmaceuticals Oncology FDA
 HSMN NewsFeed - 18 Aug 2010
Euthymics Bioscience, Inc. Appoints Industry Veterans Dr. Pierre Trân, Joan Manthis and William Pappafotopoulos to Senior Management Team
Biopharmaceuticals Personnel
 HSMN NewsFeed - 17 Aug 2010
BioMarin Acquires ZyStor Therapeutics, Inc.
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 17 Aug 2010
Lilly Halts Development of Semagacestat for Alzheimer's Disease Based on Preliminary Results of Phase III Clinical Trials
Biopharmaceuticals Neurology
 HSMN NewsFeed - 17 Aug 2010
Amarin Corporation Appoints Colin W. Stewart as President and Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2010
Curaxis Pharmaceutical Corp Elects Dr. Bert A. Spilker to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 16 Aug 2010
Selecta Biosciences Appoints Werner Cautreels, Ph.D., as Company's First CEO
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2010
Watson Plans Q4 2010 ella(R) (ulipristal acetate) Emergency Contraceptive Launch
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Aug 2010
FDA Grants Approval of ella(R) for Emergency Contraception
Biopharmaceuticals FDA
 HSMN NewsFeed - 13 Aug 2010
US WorldMeds Acquires Solstice Neurosciences
Biopharmaceuticals Neurology Mergers & Acquisitions
 HSMN NewsFeed - 13 Aug 2010
Inspire Names Dr. Charles Johnson as Executive Vice President of Research and Development and Chief Medical Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 13 Aug 2010
Human Genome Sciences Names Tuomo Pätsi Vice President, HGS Europe
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2010
U.S. District Court Rules Against Lilly Regarding Strattera Patent
Biopharmaceuticals Generics Litigation
 HSMN NewsFeed - 12 Aug 2010
Darl Moreland Joins Alexza Pharmaceuticals as Vice President, Quality
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2010
Genocea Biosciences Hires Chip Clark as Chief Business Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 12 Aug 2010
Mercator Licenses Pioneering Technology from MD Anderson Cancer Center and Closes $2M Seed Round
Biopharmaceuticals Oncology Venture Capital Licensing
 HSMN NewsFeed - 12 Aug 2010
Meda: Ezogabine Receives Positive Vote From FDA Advisory Committee
Biopharmaceuticals Neurology FDA
Older Biopharmaceutical stories   Return to NewsFeed  
FindReps - screen and connect with rep candidates anonymously, in real time.

FindReps: Screen and connect with Medical Sales Rep candidates (Direct Reps and Independents) – anonymously, in real time.


RepJobs - Job Opportunities for Direct Sales Reps and New Product Lines for Independents!

RepJobs: Job Opportunities for Direct Sales Reps and New Product Lines for Independents!